Lawsuits & Litigation Coverage

Active mass tort and class-action litigation tracked as a news beat. Procedural posture, named defendants, MDL status, and the filings that move the cases. Updated as courts move.

Active litigation coverage

Brick welcome sign at the Holcomb Gate entrance to Marine Corps Base Camp Lejeune reading 'CAMP LEJEUNE — Home of Expeditionary Forces in Readiness,' with the Marine Corps Eagle, Globe, and Anchor emblem mounted on the right side

Welcome sign at the Holcomb Gate entrance to Marine Corps Base Camp Lejeune in North Carolina, the installation at the center of the 1953–1987 water-contamination litigation (file photo, 2008). Photo: U.S. Marine Corps via DVIDS (Public domain).

Lawsuits

Camp Lejeune Litigation: Settlements and Lawsuits Three Decades After

Three decades after Marines and their families drank contaminated water at Camp Lejeune, the Justice Department has paid roughly $571 million of $795 million in approved settlement offers — fewer than 1% of the ~407,000 administrative claims filed. Ongoing news coverage.

May 27, 20269 min read

A gloved stylist works a chemical hair relaxer through a client's hair

A stylist applies a chemical hair relaxer to a client. More than 11,500 women allege in MDL 3060 that long-term use of chemical hair relaxers caused uterine, ovarian, and endometrial cancer. Photo: Envato Elements.

Lawsuits

Hair Relaxer MDL: Ongoing Coverage of the Cancer Litigation Against L'Oreal, Revlon, and Others

Over 11,500 women have filed in MDL 3060, alleging chemical hair relaxer products caused uterine, ovarian, and endometrial cancer. Bellwether trials are expected in 2027. Ongoing coverage.

May 27, 20266 min read

The Thomas F. Eagleton United States Courthouse in St. Louis, Missouri

The Thomas F. Eagleton U.S. Courthouse in St. Louis, a federal court venue for multidistrict litigation (file photo). Photo: U.S. District Court for the Eastern District of Missouri via Wikimedia Commons (Public domain).

Lawsuits

Mass Tort Litigation: Ongoing Coverage of Major Mass Tort Cases

411 Press tracks the major active mass tort litigations as ongoing news beats. Nearly 200,000 cases pending across 159 active federal MDLs as of May 2026.

May 27, 20268 min read

A container of Similac infant formula on a wood surface

Similac infant formula, made by Abbott Laboratories — a named defendant in MDL 3026 alleging the company failed to warn that cow's-milk-based formula carries elevated necrotizing enterocolitis risk for premature infants. Photo: ajay_suresh / Wikimedia Commons (CC BY 2.0).

Lawsuits

NEC Baby Formula Litigation: $495M Verdict Upheld, Federal Bellwether July 2026

Ongoing news coverage of MDL 3026 and parallel state-court litigation against Abbott and Mead Johnson. A $495 million verdict was upheld in May 2026. Federal bellwether trials start July 6.

May 27, 20267 min read

Ozempic semaglutide injection pen with English-language North American market labeling, product close-up on a neutral background

An Ozempic (semaglutide) injection pen with North American English-language labeling, the product at the center of MDL 3094. Photo: Dennis Sylvester Hurd / Wikimedia Commons (CC0).

Lawsuits

Ozempic Litigation: Ongoing Coverage of the GLP-1 Mass Tort

Ongoing news coverage of MDL 3094 and MDL 3163 — the federal multidistrict litigations against Novo Nordisk and Eli Lilly over gastrointestinal injuries and vision loss linked to GLP-1 drugs.

May 27, 20268 min read

Social media apps on a smartphone display. The platforms named in MDL 3047 face allegations of design features that harm teen mental health. Photo: mikemacmarketing / Wikimedia Commons (CC BY 2.0).

Lawsuits

Social Media Addiction Litigation: Ongoing Coverage of MDL 3047

Ongoing news coverage of MDL 3047 — the federal litigation against Meta, ByteDance, Snap, and Alphabet over platform design that allegedly harmed children's mental health. K.G.M. v. Meta returned a $6M verdict in March 2026.

May 27, 20266 min read